Faeth Therapeutics, Inc. (FTH) quarterly income statement — complete revenue, gross profit & net income history
Faeth Therapeutics, Inc. (FTH) annual income statement — 8-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | -4.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 17K | 0 | 132.96M | 0 | -4.85M | 0 | 0 | 139K | 140K | 135K | 137K | 135K | 455K | 491K | 0 | 469K | 451K | 440K | 448K | 329K |
| COGS % of Revenue | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -17K | 0 | -132.96M | 0 | 0 | 0 | 0 | -139K | -140K | -135K | -137K | -135K | -455K | -491K | 0 | -469K | -451K | -440K | -448K | -329K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 100% | 100% | 100% | - | - | - | - | - | 71.22% | -0.89% | -11.59% | 100% | -42.55% | -231.62% | -260.66% | -357.14% | - |
| Operating Expenses | 22.09M | 18.39M | 37.67M | 4.96M | 4.85M | 5.21M | 7.27M | 7.18M | 7.68M | 7.65M | 8.59M | 8.01M | 7.28M | 9.69M | 11.01M | 11.51M | 13.49M | 10.27M | 12.04M | 9.08M |
| OpEx % of Revenue | - | - | - | - | -100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 10.35M | 9.21M | 19.71M | 2.79M | 2.31M | 2.67M | 3.55M | 2.69M | 3.05M | 3.07M | 3.68M | 3.51M | 3.46M | 5.21M | 5.8M | 4.97M | 4.3M | 3.88M | 4.58M | 3.13M |
| SG&A % of Revenue | - | - | - | - | -47.72% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 11.74M | 9.18M | 17.96M | 2.17M | 2.54M | 2.53M | 3.73M | 4.49M | 4.64M | 4.58M | 4.92M | 4.49M | 3.82M | 4.48M | 5.2M | 6.54M | 9.19M | 6.39M | 7.46M | 5.96M |
| R&D % of Revenue | - | - | - | - | -52.28% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.09M | -18.39M | -170.63M | -4.96M | -4.85M | -5.21M | -7.27M | -7.32M | -7.82M | -7.79M | -8.73M | -8.14M | -7.74M | -10.19M | -11.01M | -11.98M | -13.94M | -10.71M | -12.49M | -9.41M |
| Operating Margin % | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -355.29% | -253.15% | -2245.71% | 32.31% | 37.99% | 33.15% | - | - | - | - | 20.69% | 32.04% | 44.5% | 4.92% | 11.84% | -27.27% | -35.14% | -9.48% | -56.69% | -85.4% |
| EBITDA | -22.07M | -18.36M | -170.6M | -4.92M | -4.82M | -5.17M | -7.24M | -6.99M | -7.49M | -7.46M | -8.59M | -8.01M | -7.28M | -9.69M | -10.65M | -11.51M | -13.49M | -10.27M | -12.04M | -9.08M |
| EBITDA Margin % | - | - | - | - | 99.3% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -358.15% | -255.21% | -2256.31% | 29.59% | 35.7% | 30.7% | - | - | - | - | 19.31% | 30.44% | 46.02% | 5.63% | 11.54% | -26.72% | -32.51% | -6.31% | -52.95% | -81.43% |
| D&A (Non-Cash Add-back) | 17K | 24K | 30K | 34K | 34K | 37K | 34K | 331K | 332K | 328K | 137K | 135K | 455K | 491K | 358K | 469K | 451K | 440K | 448K | 329K |
| EBIT | -22.09M | -16.01M | -170.24M | -4.71M | -4.56M | -4.93M | -6.85M | -7.75M | -7.23M | -7.12M | -7.96M | -7.38M | -7.09M | -9.35M | -10.13M | -12.23M | -13.41M | -10.36M | -12.16M | -9.06M |
| Net Interest Income | 1.78M | 2.26M | 392K | 220K | 283K | 311K | 392K | 505K | 570K | 645K | 740K | 795K | 844K | 914K | 927K | 609K | 505K | 177K | 67K | 28K |
| Interest Income | 1.78M | 2.26M | 392K | 223K | 289K | 321K | 405K | 522K | 591K | 669K | 768K | 826K | 877K | 952K | 969K | 609K | 515K | 349K | 310K | 334K |
| Interest Expense | 0 | 0 | 0 | 3K | 6K | 10K | 13K | 17K | 21K | 24K | 28K | 31K | 33K | 38K | 42K | 0 | 10K | 172K | 243K | 306K |
| Other Income/Expense | 1.69M | 2.38M | 391K | 240K | 282K | 270K | 410K | -447K | 570K | 645K | 738K | 728K | 613K | 799K | 831K | -252K | 525K | 177K | 82K | 47K |
| Pretax Income | -20.4M | -16.01M | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M | -7.12M | -9.39M | -10.18M | -12.23M | -13.42M | -10.54M | -12.4M | -9.37M |
| Pretax Margin % | - | - | - | - | 94.19% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -20.4M | -16.01M | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M | -7.12M | -9.39M | -10.18M | -12.23M | -13.42M | -10.54M | -12.4M | -9.37M |
| Net Margin % | - | - | - | - | 94.19% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -346.44% | -224.29% | -2380.13% | 39.29% | 37.01% | 30.89% | - | - | - | - | 21.47% | 39.39% | 46.9% | 10.91% | 17.96% | -30.6% | -38.52% | -7.82% | -55.61% | -82.54% |
| Net Income (Continuing) | -20.4M | -16.01M | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M | -7.12M | -9.39M | -10.18M | -12.23M | -13.42M | -10.54M | -12.4M | -9.37M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.79 | -2.84 | -131.45 | -3.74 | -3.62 | -3.91 | -5.45 | -6.18 | -5.77 | -5.69 | -0.32 | -0.30 | -0.28 | -0.31 | -0.33 | -0.40 | -0.42 | -0.34 | -0.40 | -0.31 |
| EPS Growth % | 78.18% | 27.37% | -2311.93% | 39.48% | 37.26% | 31.28% | - | - | - | - | 3.03% | 25% | 33.33% | 8.82% | 17.5% | -29.03% | -31.25% | -6.25% | 4.76% | -14.81% |
| EPS (Basic) | -0.79 | -2.84 | -131.45 | -3.74 | -3.62 | -3.91 | -5.45 | -6.18 | -5.77 | -5.69 | -0.32 | -0.30 | -0.28 | -0.31 | -0.33 | -0.40 | -0.42 | -0.34 | -0.40 | -0.31 |
| Diluted Shares Outstanding | 25.84M | 5.64M | 1.3M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 25.05M | 25.03M | 25.51M | 30.51M | 30.87M | 30.74M | 30.72M | 30.7M | 30.65M | 30.59M |
| Basic Shares Outstanding | 25.84M | 5.64M | 1.3M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 25.05M | 25.03M | 25.51M | 30.51M | 30.87M | 30.74M | 30.72M | 30.7M | 30.65M | 30.59M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |